Status:
COMPLETED
Implementation of Adverse Childhood Experiences (ACEs) Policy
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Adverse Childhood Experiences
Eligibility:
All Genders
Up to 5 years
Phase:
NA
Brief Summary
Adverse Childhood Experiences (ACEs) are pervasive among children with 45% experiencing at least one ACE and 10% experiencing three or more, placing them at high risk for toxic stress and symptomatolo...
Detailed Description
Adverse Childhood Experiences (ACEs) are defined as traumatic events occurring before age 18, such as maltreatment, life-threatening accident, harsh migration experiences or exposure to violence. ACEs...
Eligibility Criteria
Inclusion
- Children ages 0-5 scheduled for wellness visit for upcoming week
- Caregiver of child is 18 years or older with legal custody or authority to arrange care for child
- Caregiver provides informed consent; signs consent form and HIPAA release form as well as coronavirus disease (COVID-19) information sheet
- Caregiver agrees to complete the Pediatric Symptoms Checklist or PSC
- Caregiver provides permission for socio-demographic information about their child to be pulled from EMR records, de-identified, and shared with PI
Exclusion
- Children ages 0-5 scheduled for wellness visit for upcoming week
- Caregiver declines to provide signed informed consent, HIPAA release, or permission for socio-demographic data to be pulled from the Electronic Medical Records (EMR), de-identified and shared with PI; or declines to respond to 17 questions for the PSC
- Children ages 6-18 scheduled for wellness visits
- Children ages 0-5 scheduled for wellness visits outside the study data collection windows or at clinics not providing pediatric care
- Caregiver does not have legal guardianship or written authority to arrange care for the child
Key Trial Info
Start Date :
February 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
7645 Patients enrolled
Trial Details
Trial ID
NCT04916587
Start Date
February 21 2022
End Date
April 30 2024
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Borrego Health
Desert Hot Springs, California, United States, 92240